Recruiting PHASE4 INTERVENTIONAL 2-arm NCT03264352

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes (IPAD)

Sponsor: XueQing Yu

Conditions Adverse Event Blood Pressure Cardiovascular Risk Factor Diabetes Mellitus, Type 2 Prehypertension

Interventions Allisartan Isoproxil Amlodipine 5mg Standard treatment by current guideline

Updated 11 times since 2017 Last updated: Mar 10, 2025 Started: Feb 1, 2018 Primary completion: Sep 30, 2025 Completion: Sep 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Adverse Event and Blood Pressure, this trial is actively recruiting participants. The trial is conducted by XueQing Yu and has accumulated 11 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

11 versions recorded

Apr 2025 — Present [monthly]

Recruiting PHASE4
Sep 2024 — Apr 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Mar 2023 — Jul 2024 [monthly]

Recruiting PHASE4
Feb 2022 — Mar 2023 [monthly]

Recruiting PHASE4

▶ Show 6 earlier versions

Jun 2021 — Feb 2022 [monthly]

Recruiting PHASE4
Jan 2021 — Jun 2021 [monthly]

Recruiting PHASE4
Dec 2019 — Jan 2021 [monthly]

Recruiting PHASE4
May 2019 — Dec 2019 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jun 2018 — May 2019 [monthly]

Not Yet Recruiting PHASE4
Sep 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

XueQing Yu

Data source: Guangdong Provincial People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China